In vitro performance of dutasteride-nanostructured lipid carriers coated with lauric acid-chitosan oligomer for dermal delivery
Dutasteride, licensed as an oral medicine for the treatment of benign prostatic hypoplasia, has been investigated as a treatment for androgenic alopecia. In this study, the potential for dustasteride to be delivered topically in order to reduce systemic exposure, irritation of the skin, and also cyt...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI
2020
|
Subjects: | |
Online Access: | http://eprints.utm.my/93589/1/NorhayatiMohamedNoor2020_InVitroPerformanceofDutasteride.pdf |